MDS Analytical Technologies has launched the Molecular Devices Spectratest LM1 Luminescence Validation Package.
The package enables users to test optical specifications of MDS Analytical Technologies' microplate readers.
'All Spectratest Validation and Compliance Tools provide users an automated, traceable method for instrument validation that delivers less variability than traditional techniques and interrogates 13 critical parameters of instrument performance,' said Andy Boorn, president of MDS.
MDS provides additional tools for IQ/OQ/PQ validation, as well as software validation, and offers compliance tools to help users meet quality and regulatory requirements, such as US Food and Drug Administration (FDA) 21CFR Part 11 compliance and Good Laboratory and Manufacturing Practices (GxP).
The package is designed for the validation of optical performance of luminescence-microplate readers manufactured by MDS, including all Molecular Devices Spectramax L and M Series Readers and Flexstation 3 Readers.
All elements of the validation process are handled automatically by protocols within the Softmax Pro Software Suite, which comes standard with all Spectramax and Flexstation Readers.
The package incorporates a luminescence-validation microplate that enables users to test specifications that are critical to instrument performance, including background noise, background spike, lower limit of detection, crosstalk, linearity, relative luminescence units, well-to-well precision, left-to-right bias, top-to-bottom bias and kinetic noise, spike and drift in the low and high signal ranges.
The Spectratest range of validation and compliance packages also includes the Spectratest ABS1 Absorbance and FL1 Fluorescence Validation Packages, which afford users the ability to validate the performance of absorbance and fluorescence-microplate readers manufactured by MDS.
